Where is EQRx headquartered?

EQRx is located in Cambridge, MA.

Who invested in EQRx?

EQRx has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for EQRx?

EQRx closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

eqrx.com

EQRx

EQRx is a Massachusetts-based pharmaceutical company that develops and commercializes novel therapies and medicines for the treatment of cancer.

Business Model:

Revenue: $0

Employees: 201-500

Geographic Data

Address: 50 Hampshire Street

City: Cambridge

State: MA

Zip: 02139

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$1B

Raised Total:

$2B

Social

Facebook

Twitter

Crunchbase

Metrics

827,012Website Global Rank

44,984Website Monthly Traffic

Twitter Followers

Description

EQRx is a Massachusetts-based pharmaceutical company that develops and commercializes novel therapies and medicines for the treatment of cancer.

Contact Phone:
+16173152255

Contact Email:

IPO Details

EQRx went public on 12/17/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
12/17/2021

IPO Valuation:
$4B

Ticker Symbol:
EQRX

Amount Raised:
$552M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
12/2021	IPO SPAC		$1.8B
12/2021	Post-IPO Equity		$0	Andreessen Horowitz Avidity Partners Bain Capital Life Sciences Boxer Capital BVF Partners Casdin Capital Corvex Fidelity Management and Research Company Franklin Templeton Investments Invus Mubadala Mubadala Capital Ventures Rock Springs Capital SB Life Science Verily Andreessen Horowitz Avidity Partners Bain Capital Life Sciences Boxer Capital BVF Partners Casdin Capital Corvex Fidelity Management and Research Company Franklin Templeton Investments Invus Mubadala Mubadala Capital Ventures Rock Springs Capital SB Life Science Verily
12/2019	Equity		$100M
1/2021	Series B	8	$500M	Section 32 Nextech Invest GV Casdin Capital Bain Capital Life Sciences ARCH Venture Partners Arboretum Ventures Andreessen Horowitz
1/2020	Series A	9	$200M	GV Section 32 Nextech Invest Exor Seeds Casdin Capital Bain Capital Life Sciences ARCH Venture Partners Arboretum Ventures Andreessen Horowitz GV
12/2021	Post-IPO Equity	15	$1.2B	Andreessen Horowitz Avidity Partners Bain Capital Life Sciences Boxer Capital BVF Partners Casdin Capital Corvex Fidelity Management and Research Company Franklin Templeton Investments Invus Mubadala Mubadala Capital Ventures Rock Springs Capital SB Life Science Verily Andreessen Horowitz Avidity Partners Bain Capital Life Sciences Boxer Capital BVF Partners Casdin Capital Corvex Fidelity Management and Research Company Franklin Templeton Investments Invus Mubadala Mubadala Capital Ventures Rock Springs Capital SB Life Science Verily

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details